目的通过对医院信息系统(Hospital Information System,以下简称HIS系统)中的传染病信息管理系统应用情况的调查,旨在了解医疗机构在传染病报告管理方面的信息采集、信息管理的规范化情况,为完善HIS系统中传染病管理模块提供科学依据。...目的通过对医院信息系统(Hospital Information System,以下简称HIS系统)中的传染病信息管理系统应用情况的调查,旨在了解医疗机构在传染病报告管理方面的信息采集、信息管理的规范化情况,为完善HIS系统中传染病管理模块提供科学依据。方法采取问卷调查的方法,对辖区内建设有HIS系统的医疗机构进行调查。结果 50%建有HIS系统的单位建立了传染病信息管理子系统,但该子系统在信息浏览方式、来源、与HIS系统中其他子系统(医生工作站系统、检验系统、影像系统)的链接等方面均存在差异。结论基于HIS系统中的传染病信息管理系统,在各医疗机构中建设情况尚不统一,同时在功能方面需进一步完善、规范,从而提高传染病管理系统对传染病报告管理、控制水平。展开更多
Inflammatory bowel diseases(IBDs), particularly Crohn's disease(CD) and ulcerative colitis(UC), are associated with a variety of extra-intestinal manifestations(EIMs).About 36% of IBD patients have at least one EI...Inflammatory bowel diseases(IBDs), particularly Crohn's disease(CD) and ulcerative colitis(UC), are associated with a variety of extra-intestinal manifestations(EIMs).About 36% of IBD patients have at least one EIM, which most frequently affect the joints, skin, eyes and the biliary tract.The EIMs associated with IBD have a negative impact on patients with UC and CD, and the resolution of most of them parallels that of the active IBD in terms of timing and required therapy;however, the clinical course of EIMs such as axial arthritis, pyoderma gangrenosum, uveitis, and primary sclerosing cholangitis is independent of IBD activity.The peripheral and axial arthritis associated with IBD have traditionally been treated with simple analgesics, non-steroidal anti-inflammatory drugs, steroids, sulfasalazine, methotrexate, local steroid injections and physiotherapy, but the introduction of biological response modifi ers such as tumor necrosis factor-α blockers, has led to further improvements.展开更多
文摘目的通过对医院信息系统(Hospital Information System,以下简称HIS系统)中的传染病信息管理系统应用情况的调查,旨在了解医疗机构在传染病报告管理方面的信息采集、信息管理的规范化情况,为完善HIS系统中传染病管理模块提供科学依据。方法采取问卷调查的方法,对辖区内建设有HIS系统的医疗机构进行调查。结果 50%建有HIS系统的单位建立了传染病信息管理子系统,但该子系统在信息浏览方式、来源、与HIS系统中其他子系统(医生工作站系统、检验系统、影像系统)的链接等方面均存在差异。结论基于HIS系统中的传染病信息管理系统,在各医疗机构中建设情况尚不统一,同时在功能方面需进一步完善、规范,从而提高传染病管理系统对传染病报告管理、控制水平。
文摘Inflammatory bowel diseases(IBDs), particularly Crohn's disease(CD) and ulcerative colitis(UC), are associated with a variety of extra-intestinal manifestations(EIMs).About 36% of IBD patients have at least one EIM, which most frequently affect the joints, skin, eyes and the biliary tract.The EIMs associated with IBD have a negative impact on patients with UC and CD, and the resolution of most of them parallels that of the active IBD in terms of timing and required therapy;however, the clinical course of EIMs such as axial arthritis, pyoderma gangrenosum, uveitis, and primary sclerosing cholangitis is independent of IBD activity.The peripheral and axial arthritis associated with IBD have traditionally been treated with simple analgesics, non-steroidal anti-inflammatory drugs, steroids, sulfasalazine, methotrexate, local steroid injections and physiotherapy, but the introduction of biological response modifi ers such as tumor necrosis factor-α blockers, has led to further improvements.
